NASDAQ: RGEN
Repligen Corp Stock Ownership - Who owns Repligen?

Insider buying vs selling

Have Repligen Corp insiders been buying or selling?

Buy
Sell
NameRoleDateSharesPriceValue
Olivier LoeillotCEO2026-09-215,426$141.79
$769.35kBuy
Olivier LoeillotCEO2026-09-215,426$180.00
$976.68kSell
Olivier LoeillotCEO2026-09-043,035$165.90
$503.51kSell
Olivier LoeillotCEO2026-09-032,842$169.61
$482.03kSell
Violetta HughesCAO2026-09-01277$170.02
$47.10kSell
Olivier LoeillotCEO2026-08-205,426$180.00
$976.68kSell
Olivier LoeillotCEO2026-08-205,426$141.79
$769.35kBuy
Jason K. GarlandCFO2026-07-16530$150.00
$79.50kSell
Jason K. GarlandCFO2026-06-25733$145.00
$106.29kSell
Glenn P. MuirDirector2026-05-072,434$38.76
$94.34kBuy

1 of 5

RGEN insiders have sold more... subscribe to Premium to read more.
Net Insider Buy/Sell (L12M) Ownership

Be the first to know when RGEN insiders and whales buy or sell their stock.

RGEN Shareholders

What type of owners hold Repligen Corp stock?

Institutional
Insider
Retail
NameHoldSharesValueType
Bvf Partners L P19.60%11,060,200$2.07BInsider
Roy T. Eddleman13.62%7,685,810$1.44BInsider
Paul Schimmel1.18%665,106$124.21MInsider
Alexander Rich0.77%436,500$81.52MInsider
Walter C. Herlihy0.47%262,430$49.01MInsider
James R. Rusche0.26%146,816$27.42MInsider
Daniel P. Witt0.21%117,833$22.01MInsider
Karen A. Dawes0.16%92,816$17.33MInsider
Anthony Hunt0.16%89,062$16.63MInsider
Glenn L. Md Cooper0.11%59,709$11.15MInsider

1 of 3

RGEN vs Medical Stocks

TickerInst. %Insider %Net Insider (L12M)Net Insider (L3M)
RGEN0.12%37.34%Net SellingNet Selling
COO0.11%1.32%Net BuyingNet Buying
BAX0.11%16.12%Net SellingNet Selling
ATR0.10%4.04%Net SellingNet Selling
STVN0.01%83.89%Net SellingNet Selling

Repligen Stock Ownership FAQ

Who owns Repligen?

Repligen (NASDAQ: RGEN) is owned by 0.12% institutional shareholders, 37.34% Repligen insiders, and 62.54% retail investors. Bvf Partners L P is the largest individual Repligen shareholder, owning 11.06M shares representing 19.60% of the company. Bvf Partners L P's Repligen shares are currently valued at $2.04B.

If you're new to stock investing, here's how to buy Repligen stock.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.